Top Boston, MA Companies With Best Stability & Growth (3,140)

Strong Revenue Growth: Results indicate net sales increased year over year and management signaled continued growth ahead. Active customers and spend per customer also rose, supporting resumed top‑line momentum.

Profitability: Disclosures show adjusted EBITDA and margins expanded, reflecting improving operating leverage. This points to better unit economics as scale increases.

Healthy Cash Flow: The company generated record free cash flow in the most recent year. Strong cash generation supports reinvestment in services, membership, and healthcare initiatives.

Investor Backing & Capital Strength: Nordic Capital announced a majority stake in July 2025 with the stated goal of accelerating expansion, signaling fresh capital and scaling support. The deal’s expected H2 2025 close aligns with plans for go-to-market acceleration and potential M&A.

Product Line Growth: Arcadia acquired CareJourney in June 2024 and subsequently launched AI-enabled solutions in February 2025 tied to that acquisition. These moves broaden benchmark datasets and deepen analytics across value-based care use cases.

Strong Market Position & Advantage: The company highlights large-scale data operations and a marquee client roster and continues to run its Aggregate user conference, indicating active enterprise traction. KLAS’ 2025 report shows an improved Arcadia Analytics score, suggesting rising customer perception.

Profitability: Reported GAAP income from operations of $292 million and GAAP net income of $342 million in 2025 signal sustained profitability. Adjusted EBITDA of $633 million further underscores margin expansion at scale.

Healthy Cash Flow: Free cash flow reached $608 million in 2025, evidencing strong cash conversion. This cash generation supports ongoing investment while maintaining growth in the core platform.

Resilient & Sustainable Growth: Annualized recurring run‑rate surpassed $2.0 billion at year‑end 2025 (up 26%), and 2026 guidance calls for 20–22% growth in recurring gross profit. Record net adds lifted total locations to ~164,000, supporting continued expansion across the base.

Strong Revenue Growth: Recent results show FY2025 revenue up strongly with a record Q4, and FY2026 guidance still calling for double‑digit top‑line expansion. Management updates indicate sustained momentum with an increased full‑year outlook.

Profitability: Q4 FY2025 achieved GAAP profitability with improving non‑GAAP operating margins and strong free cash flow, signaling increasing efficiency alongside scale. Commentary highlights margin expansion and solid cash generation as the business matures.

Market Expansion: International revenue accelerated and the company is extending beyond email into SMS/WhatsApp and a broader B2C CRM, supporting multi‑product and geographic growth. Customer counts rose meaningfully from year‑end 2024 to year‑end 2025.

Investor Backing & Capital Strength: Fresh capital includes a $50M Series D on April 9, 2026 led by Boehringer Ingelheim and a 2025 Series C with Dassault Systèmes/Medidata to fund commercialization and platform scaling. Feedback suggests these transactions reflect strong external confidence and provide runway to advance regulatory and launch efforts.

Product Line Growth: Multiple FDA authorizations (Rejoyn in 2024; CT‑132 in 2025), positive Phase 3 data for CT‑155, and acquisition of Better Therapeutics’ assets expand the portfolio across psychiatry, neurology, and cardiometabolic conditions. A 2026 Ultrahuman partnership further extends migraine technology into adjacent offerings.

Strategic Partnerships: Multi‑year collaborations with Boehringer Ingelheim and Otsuka, plus ecosystem ties with Dassault Systèmes/Medidata and Ultrahuman, underpin development and prospective commercialization. These alliances distribute risk and provide capabilities and channels that many peers lack.

Strong Revenue Growth: Recent results show FY2025 revenue around $1.9B growing year over year, with Q4 2025 also up. FY2026 guidance of roughly $1.99–$2.05B indicates continued top-line expansion.

Profitability: 2025 flipped to positive GAAP net income with $42.3M for the year and $50.1M in Q4, alongside adjusted EBITDA of $215.5M and strong free cash flow. These results point to improving earnings power and cash generation.

Strategic Partnerships: A long‑term Yahoo agreement underpins open‑web scale while new ties with Microsoft (display), Apple News/Stocks, and CTV extensions with Paramount and LG, plus major publisher wins, broaden distribution and demand.

Strong Revenue Growth: Company-reported year-over-year ARR gains and a record net-new revenue quarter signal accelerating topline momentum into 2025–2026. Feedback suggests these gains align with rising platform engagement and enterprise standardization.

Innovation-Driven Growth: Rapid uptake of new GenAI capabilities—described as the fastest-adopted features in company history—indicates innovation is driving deeper usage. Ongoing launches like agentic testing and frequent releases reinforce an active R&D engine.

Product Line Growth: Expansion from web and API into accessibility, performance, and mobile testing broadens the addressable platform. Feedback suggests growing multi-product adoption within the unified suite.

Strong Revenue Growth: Company communications describe record revenue in Q4 FY26, over $1B in FY24 billings, and a continued ARR growth trajectory, indicating sustained top-line momentum. Additional operating signals such as large quarterly platform throughput and new logo additions suggest ongoing demand and scale expansion.

Profitability: Statements note a profitability turnaround post-2023 with further profit gains into 2025, alongside an emphasis on "profitable growth" and exceeding the "rule of 40" in FY25. This reflects improving margin discipline while scaling operations.

Innovation-Driven Growth: Frequent references to AI-native capabilities (e.g., Coupa Navi agents) and tuck-in acquisitions (e.g., Cirtuo, Scoutbee) indicate product-led expansion fueling adoption. Analyst recognitions and customer additions are presented as outcomes of this innovation cadence.

Investor Backing & Capital Strength: A $200M Series C in July 2024 that Forbes reported valued the company at $1B, along with reiterated coverage from outlets like SiliconANGLE and CB Insights, indicates substantial runway and investor confidence. These late‑stage funds are positioned to support product expansion and go‑to‑market as the firm scales.

Market Expansion: U.S. Customs and Border Protection signed a two‑year contract in 2025 expanding its use of Altana’s AI platform, and Atlas was listed on the U.S. GSA Multiple Award Schedule in April 2024 for agency access. New customer wins such as L.L.Bean and government availability signal broader reach across public and private sectors.

Strategic Partnerships: Partnerships with Maersk for integrated compliance and named enterprise customers like L.L.Bean demonstrate traction with blue‑chip operators. These relationships support platform adoption in high‑stakes compliance and logistics contexts.

Market Expansion: Headcount and office disclosures show an expansion from 35+ to 40+ offices, alongside new capacity such as the Hyderabad Operations Center. These moves indicate a broader global presence to meet demand.

Strong Hiring & Retention: Recent materials cite 2,783 new hires in 2024 and over 2,850 promotions, with labor‑market analytics indicating year‑over‑year headcount growth through 2025. These suggest sustained talent investment and scaling.

Innovation-Driven Growth: Creation of a dedicated Platform & Products unit and scaling of ZAIDYN/Max.AI signal a push toward scalable, AI‑enabled offerings. Acquisitions such as Digital Additive (2024) and Torrent Consulting (2025) further broaden Salesforce and AI capabilities.

Investor Backing & Capital Strength: A majority investment agreement by a large private‑equity sponsor at a higher valuation, with subsequent debt financing steps announced, indicates strong external capital support. This backing aligns with progress toward deal close and added resources for scaling.

Strong Market Position & Advantage: Consecutive placement as a Leader in Gartner’s DEX Magic Quadrant signals durable competitive positioning and broad enterprise adoption. Repeated recognition across major analyst frameworks points to sustained category strength.

Strong Revenue Growth: Multiple sources describe multi‑year expansion, including earlier ARR milestones and reports of revenue roughly tripling since 2021. While exact current figures are not routinely disclosed, customer and endpoint scale trend upward.

Innovation-Driven Growth: Product releases continued into 2026, including AI-assisted booking, analytics enhancements, and a Scheduling Agent, indicating sustained investment and active use. Documentation also highlights expansions such as Microsoft Graph migration tooling and automatic meeting categorization.

Strategic Partnerships: Integrations expanded across access control and workplace ecosystems (e.g., Genea, Brivo, Kisi, Avigilon/Openpath) and within Microsoft/Google stacks, embedding the platform in enterprise workflows. An acquisition of Flow and Form and device partnerships (e.g., Neat) further broadened distribution and capabilities.

Strong Market Position & Advantage: Recognition as a Leader in Gartner’s 2026 Workplace Experience Applications report signals credible execution and vision in the category. Continued presence across analyst and buyer ecosystems suggests an active install base engaging with the platform.

Strong Revenue Growth: Company disclosures indicate double-digit year-over-year revenue expansion in FY2024 and earlier milestones such as surpassing nine-figure recurring revenue. Feedback suggests momentum is reinforced by record deal size and crossing major topline thresholds.

Profitability: The business reports remaining profitable and maintaining positive cash flow while growing, signaling disciplined expansion. This combination supports stability as scale increases.

Investor Backing & Capital Strength: A majority/strategic growth investment led by a prominent private equity firm valued the company around $1.2 billion, implying confidence and resources for expansion. Additional participation from other investors further reinforces access to capital.

Investor Backing & Capital Strength: Recent late-stage funding rounds and a higher valuation are presented as clear signals of substantial capital support and investor confidence. The company indicates plans to deploy this capital toward team growth and product development across core markets.

Strong Revenue Growth: Management reports crossing a major ARR milestone with multiple years of rapid top-line expansion. Consistent year-over-year acceleration is highlighted alongside continued scaling plans.

Market Expansion: The business is extending beyond housing into healthcare and signaling international ambitions. New office hubs and active hiring across functions support broader geographic and vertical reach.

Innovation-Driven Growth: The Bank leads the FedNow instant payments rail and co-led Project Hamilton on CBDC, underscoring sustained payments and technology innovation. These initiatives expand institutional capabilities and keep the organization at the forefront of modernizing financial infrastructure.

Future-Ready Strategy: 2025 plans call for higher operating and capital spending with a larger workforce than 2024 actuals, following a year of measured execution below budget. This staged ramp signals preparedness to fund priority programs and technology investments.

Strong Market Position & Advantage: The institution is repeatedly cited for niche leadership in payments innovation, crisis‑program execution, and community development within the Federal Reserve System. This positioning supports influence and relevance as FedNow adoption grows and advisory roles expand.

Strong Market Position & Advantage: Independent analyst recognition as a Leader in The Forrester Wave (Q1 2026) and visible enterprise case references indicate competitive strength and market traction.

Innovation-Driven Growth: A 2025 rebrand to a unified Immersive One platform and regular 2025–2026 content and feature releases (e.g., AI security, DFIR, current CVEs) demonstrate sustained product innovation aligned to evolving threats.

Investor Backing & Capital Strength: Multiple sizable funding rounds and the Snap Labs acquisition to deepen cyber‑range capabilities signal sustained investor support and capital access for expansion.

Strong Revenue Growth: Public announcements highlight record U.S. growth in the most recently disclosed fiscal year, pointing to accelerating revenue traction. Subsequent signals portray continued momentum even though newer figures are not quantified publicly.

Market Expansion: Enterprise rollouts with recognizable brands and a presence across multiple regions indicate active expansion into new accounts and geographies. Positioning to capture migrations from Workplace by Meta further supports entry into additional markets.

Innovation-Driven Growth: Regular feature releases through 2025–2026 and new integrations reflect sustained product investment focused on frontline use cases. Additions like Smart Feed, offline access, and HRIS workflows suggest ongoing innovation to unlock new adoption.

Strong Revenue Growth: Recent disclosures cite surpassing $1 billion in 2023 and approximately $1.1 billion in 2024, with double‑digit momentum into the first half of 2024. These signals point to sustained top‑line expansion beyond the initial $1B milestone.

Product Line Growth: Frequent IRIS releases through 2025 (e.g., 2025.3) and new offerings such as IntelliCare EHR, Payer Connector, and HealthShare AI Assistant indicate an expanding portfolio. Added capabilities like vector support and enhanced partitioning underscore continued product investment.

Strong Brand Reputation: Multiple 2025–2026 Best in KLAS awards and IDC MarketScape leadership placements reinforce category strength in healthcare. Repeated honors for Acute Care EHR in Asia/Oceania/France and Shared Care Records in Europe suggest durable customer trust.

Strong Revenue Growth: Multiple independent fastest‑growing company lists (e.g., Inc. 5000, Financial Times, Boston Globe) and multi‑year Datadog awards that include revenue contribution criteria point to sustained topline expansion through 2025–2026. Leadership commentary and repeated recognitions align directionally to material growth prior to and following the Synechron acquisition.

Strategic Partnerships: Repeated Datadog Partner of the Year honors and Premier tier status, alongside ServiceNow Elite standing and integration into Synechron’s global practice, indicate strong platform alliances that amplify market access. Public award criteria explicitly tie recognition to partner revenue contribution and growth, reinforcing commercial impact via these relationships.

Market Expansion: The October 2025 acquisition by Synechron to form a global ServiceNow business, with references to a $1B+ revenue platform, suggests a larger go‑to‑market engine for RapDev’s offerings. Hiring signals and ongoing marketplace activity further align with expanding reach under a broader umbrella.

Market Expansion: Feedback suggests Jellyfish has broadened its customer footprint to 500+ companies while increasing ecosystem presence via coalitions and partnerships. Recent newsroom updates and partnership announcements indicate active go-to-market execution.

Innovation-Driven Growth: Feedback suggests the company is extending its platform with AI-focused capabilities such as AI Impact and a smarter assistant, alongside ongoing research on AI’s effect on engineering. Product updates and integrations signal sustained investment in R&D and feature breadth.

Investor Backing & Capital Strength: Feedback suggests Jellyfish retains a solid capital base with total funding of roughly $114.5M, anchored by a $71M Series C. Named backers and the multi-round funding timeline support continued scaling capacity.